| Trial Identifier: | D325BC00001 |
| Sponsor: | AstraZeneca |
| Start Date: | July 2021 |
| Primary Completion Date: | April 2024 |
| Study Completion Date: | April 2024 |
| Condition: | Lungs & Respiratory - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Country | Location |
|---|---|
| AR | Florida, AR, B1602DQD |
| AR | San Fernando, AR, B1646EBJ |
| AR | San Miguel de Tucuman, AR, 4000 |
| AU | Melbourne, AU, 3004 |
| AU | South Brisbane, AU, 4101 |
| CA, ON | Ajax, ON, CA, L1S 2J5 |
| CA, ON | Burlington, ON, CA, L7N 3V2 |
| CA, ON | Windsor, ON, CA, N8X-5A6 |
| CN | guangzhou, CN |
| CN | Guangzhou, CN, 510120 |
| CN | Shanghai, CN, 200032 |
| CN | Zhengzhou, CN, 450000 |
| DE | Essen, DE, 45239 |
| DE | Frankfurt, DE, 60590 |
| DE | Gauting, DE, 82131 |
| DE | München, DE, D-80336 |
| DK | Aalborg, DK, 9000 |
| DK | Hellerup, DK, 2900 |
| DK | Hvidovre, DK, 2650 |
| DK | Vejle, DK, 7100 |
| ES | Barcelona, ES, 08003 |
| ES | Madrid, ES, 28040 |
| GB | Southampton, GB, SO9 4XY |
| IN | Coimbatore, IN, 641028 |
| IN | Hyderabad, IN, 500084 |
| IN | New Delhi, IN, 100049 |
| IT | Milano, IT, 20122 |
| IT | Pisa, IT, 56100 |
| IT | Roma, IT, 00168 |
| IT | Rozzano, IT, 20089 |
| KR | Jeonju, KR, 54907 |
| KR | Seoul, KR, 06591 |
| KR | Seoul, KR, 04763 |
| KR | Seoul, KR, 05030 |
| PH | Quezon City, PH, 1100 |
| PL | Bydgoszcz, PL, 85-079 |
| PL | Ostrowiec Świętokrzyski, PL, 27-400 |
| PL | Wrocław, PL, 54-239 |
| RU | Penza, RU, 440067 |
| RU | Saratov, RU, 410012 |
| RU | Ulyanovsk, RU, 432009 |
| US, AL | Birmingham, AL, US, 35233 |
| US, CA | Newport Beach, CA, US, 92663 |
| US, CA | Northridge, CA, US, 91324 |
| US, TX | El Paso, TX, US, 79902 |
| VN | Ho Chi Minh, VN, 700000 |
| VN | Hochiminh, VN, 70000 |